The pharmaceutical sector is well-positioned for growth, thanks to growing healthcare expenses, an increasing global elderly population, and a growing prevalence of lifestyle-related diseases.
Therefore, investors looking to capitalize on the industry tailwinds may consider buying fundamentally strong pharma stocks Amneal Pharmaceuticals, Inc. (AMRX), Dr. Reddy’s Laboratories Limited (RDY), and Novo Nordisk A/S (NVO).
